Clinical cases demonstrate successful use of TRAUMAGEL during tourniquet conversion in prolonged field care, including in gunshot wounds, industrial trauma and sharp-force injuries NEW YORK, July 7, 2026 /PRNewswire/ -- Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company...
Hence then, the article about traumagel study highlights sustained hemorrhage control and tourniquet removal without rebleeding was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( TRAUMAGEL Study Highlights Sustained Hemorrhage Control and Tourniquet Removal Without Rebleeding )
Also on site :
- Jim Carrey paid $16.5 million for a Maui beachfront estate in 2016; nearly a decade later he has listed the two-house compound on Keawakapu Beach for $35 million
- Kidnapper Richard Evonitz killed himself in 2002, days after a 15-year-old escaped his apartment and identified him; Investigation Discovery’s documentary on the case arrives Oct. 7
- Indian sailors bear growing toll as another ship attacked off Oman